CCL23: A new CC chemokine involved in human brain damage

ConclusionsDespite pre‐clinical models do not seem suitable to characterize CCL23, it might be a novel promising biomarker for the early diagnosis of cerebral lesions and might facilitate the prediction of stroke patient outcome.This article is protected by copyright. All rights reserved.

Source: Journal of Internal Medicine - February 7, 2018 Category: Internal Medicine Authors: Alba Simats, Teresa Garc ía‐Berrocoso, Anna Penalba, Dolors Giralt, Gemma Llovera, Yinghua Jiang, Laura Ramiro, Alejandro Bustamante, Elena Martinez‐Saez, Francesc Canals, Xiaoying Wang, Arthur Liesz, Anna Rosell, Joan Montaner Tags: Original Article Source Type: research